The U.S. National Institutes of Health (NIH) has granted the Biotech company Vaxxas Pty. Ltd. of Australia a worldwide license to a respiratory syncytial virus (RSV) antigen known as DS2. The license will allow for the firm to create the first needle-free and room-temperature stable RSV vaccine using a novel and “cutting edge” high-density microarray […]
First Needle-Free Patch RSV Vaccine Being Created Read More »
A recent study published in U.S. Centers for Disease Control and Prevention’s (CDC) Morbidity and Mortality Weekly Report (MMWR) showed a decline in the uptake of COVID-19 shots among health care workers in the United States this year.1 During the 2023–2024 respiratory virus season, fewer than one in six health care personnel working in acute
Most U.S. Health Care Workers Reject COVID-19 Booster Shot This Year Read More »
A new World Health Organization (WHO) study published in eBioMedicine last week highlights 17 viral and bacterial pathogens that are major sources of endemic disease around the world and that WHO officials believe should be urgently prioritized for vaccine development. The study marks the WHO’s first global effort to systematically prioritize endemic pathogens with epidemic
WHO Names 17 Pathogens as Top Priorities for Global Vaccine Development Read More »
No matter how bad you think Covid policies were, they were intended to be worse. Consider the vaccine passports alone. Six cities were locked down to include only the vaccinated in public indoor places. They were New York City, Boston, Chicago, New Orleans, Washington, D.C., and Seattle. The plan was to enforce this with a
The CDC Planned Quarantine Camps Nationwide Read More »